SG Americas Securities, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10
+400.0%
81,598
+284.4%
0.00%
Q4 2022$2
-100.0%
21,228
-82.1%
0.00%
Q3 2022$18,000
-30.8%
118,918
+303.9%
0.00%
Q2 2022$26,000
-82.4%
29,443
-75.3%
0.00%
-100.0%
Q1 2022$148,000
+87.3%
119,157
+194.5%
0.00%
Q4 2021$79,000
-62.0%
40,460
-46.7%
0.00%
-100.0%
Q3 2021$208,000
+617.2%
75,925
+416.5%
0.00%
Q4 2020$29,00014,7000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders